Gene · 9170
LPAR2: lysophosphatidic acid receptor 2
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. LPAR2: lysophosphatidic acid receptor 2. Genes, record 9170. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9170
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9HBW0 | Lysophosphatidic acid receptor 2 | 348 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,528
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | LPAR2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 20 | 2025 |
| R01DK080834 | Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea | 10 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA016059 | Massey Cancer Center - Cancer Center Support Grant | 8 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 5 | 2025 |
| P30DK034854 | Integrated Epithelial and Muscosal Biology | 4 | 2025 |
| P30DK056341 | Washington University Nutrition Obesity Research Center | 4 | 2025 |
| T32AI007405 | Training Program in Immunology | 4 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
1 to 10 of 2,528Source NIH's project files
See all 2,528 nih grantsPapers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The hidden cost of antibiotics: microbial dysbiosis-induced SCFA imbalance and its underlying mechanisms. | Front Immunol | 2026 | 42769955 | PubTator, text mining | PubMed |
| LPA₃ signaling and biological functions: from physiological regulation to disease-targeted therapy. | Mol Biol Rep | 2026 | 42742769 | PubTator, text mining | PubMed |
| Universal pipeline for high-resolution GPCR structure determination. | Nat Struct Mol Biol | 2026 | 42665663 | PubTator, text mining | PubMed |
| Lactic acid exposure alters lysophosphatidic acid receptor-mediated regulation of growth and motility in pancreatic cancer cells. | Mol Cell Biochem | 2026 | 42663874 | PubTator, text mining | PubMed |
| Oxytocin Mitigates VEGF Expression in Differentiated RPE cells - A Novel Therapeutic Approach for Diabetic Retinopathy. | Biomed Transl Sci | 2026 | 42583586 | PubTator, text mining | PubMed |
| Dysbiosis-Associated Lysophosphatidic Acid Primes Immune Checkpoint Inhibitor-Induced Intestinal Barrier Dysfunction via the Lysophosphatidic Acid Receptor 2-Myosin Light Chain Kinase Axis. | Cell Mol Gastroenterol Hepatol | 2026 | 42562136 | PubTator, text mining | PubMed |
| Integrated analysis of cell-in-cell related genes and immune microenvironment in heart failure. | Front Cell Dev Biol | 2026 | 42181687 | PubTator, text mining | PubMed |
| Construction of an actin cytoskeleton-related gene signature for predicting prognosis and therapeutic response in glioblastoma: based on machine learning. | Transl Cancer Res | 2026 | 42180858 | PubTator, text mining | PubMed |
| Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties. | Discov Oncol | 2026 | 42174273 | PubTator, text mining | PubMed |
| Annexin A1 and its membrane receptor complex: Implications for immune regulation and autoimmune disease mechanisms. | Autoimmun Rev | 2026 | 42162635 | PubTator, text mining | PubMed |
1 to 10 of 3,539
See all 3,539 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9170
GET https://conductscience.org/api/genes/v1/9170/grants?page=2